Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Targeted Lung Deposition From Nebulization Is Not Improved in the Lateral Decubitus Position in Healthy Volunteers.

Reychler G, San Miguel-Pagola M, Aubriot AS, Herrero-Cortina B, Lecocq V, Hesse M, Liistro G, Jamar F.

Respir Care. 2019 Sep 10. pii: respcare.06978. doi: 10.4187/respcare.06978. [Epub ahead of print]

PMID:
31506338
2.

High-power tunable low-noise coherent source at 1.06  μm based on a surface-emitting semiconductor laser.

Chomet B, Zhao J, Ferrieres L, Myara M, Guiraud G, Beaudoin G, Lecocq V, Sagnes I, Traynor N, Santarelli G, Denet S, Garnache A.

Appl Opt. 2018 Jun 20;57(18):5224-5229. doi: 10.1364/AO.57.005224.

PMID:
30117985
3.

CRDS with a VECSEL for broad-band high sensitivity spectroscopy in the 2.3 μm window.

Čermák P, Chomet B, Ferrieres L, Vasilchenko S, Mondelain D, Kassi S, Campargue A, Denet S, Lecocq V, Myara M, Cerutti L, Garnache A.

Rev Sci Instrum. 2016 Aug;87(8):083109. doi: 10.1063/1.4960769.

PMID:
27587102
4.

Tailoring metal-organic framework catalysts by click chemistry.

Savonnet M, Camarata A, Canivet J, Bazer-Bachi D, Bats N, Lecocq V, Pinel C, Farrusseng D.

Dalton Trans. 2012 Apr 14;41(14):3945-8. doi: 10.1039/c2dt11994c. Epub 2012 Jan 13.

PMID:
22240581
5.

Catalysis of transesterification by a nonfunctionalized metal-organic framework: acido-basicity at the external surface of ZIF-8 probed by FTIR and ab initio calculations.

Chizallet C, Lazare S, Bazer-Bachi D, Bonnier F, Lecocq V, Soyer E, Quoineaud AA, Bats N.

J Am Chem Soc. 2010 Sep 8;132(35):12365-77. doi: 10.1021/ja103365s.

PMID:
20715825
6.

Generic postfunctionalization route from amino-derived metal-organic frameworks.

Savonnet M, Bazer-Bachi D, Bats N, Perez-Pellitero J, Jeanneau E, Lecocq V, Pinel C, Farrusseng D.

J Am Chem Soc. 2010 Apr 7;132(13):4518-9. doi: 10.1021/ja909613e.

PMID:
20232865
7.

A comparative pharmacokinetic and pharmacodynamic study of conventional and sustained-release preparations of acebutolol in healthy volunteers.

Fleurot O, Lecocq B, Lecocq V, Le Liboux A, Montay G, Frydman A, Jaillon P.

Fundam Clin Pharmacol. 1991;5(7):601-9.

PMID:
1778538
8.

Effects of bepridil and CERM 4205 (ORG 30701) on the relation between cardiac cycle length and QT duration in healthy volunteers.

Lecocq B, Lecocq V, Prost PL, Fleurot O, Boisson P, Jaillon P.

Am J Cardiol. 1990 Sep 1;66(5):636-41.

PMID:
2203243
9.

Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.

Lecocq B, Funck-Brentano C, Lecocq V, Ferry A, Gardin ME, Devissaguet M, Jaillon P.

Clin Pharmacol Ther. 1990 Mar;47(3):397-402.

PMID:
2311339
10.

The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.

Poirier JM, Jaillon P, Lecocq B, Lecocq V, Ferry A, Cheymol G.

Eur J Clin Pharmacol. 1990;38(6):579-82.

PMID:
2373132
11.

Physiologic relation between cardiac cycle and QT duration in healthy volunteers.

Lecocq B, Lecocq V, Jaillon P.

Am J Cardiol. 1989 Sep 1;64(8):481-6.

PMID:
2570522
12.

Effects of falipamil (AQ-A 39) on heart rate and blood pressure in resting and exercising healthy volunteers.

Naudascher M, Jaillon P, Lecocq B, Lecocq V, Ferry A, Hilaire J, Maria JF.

J Cardiovasc Pharmacol. 1989 Jul;14(1):1-5.

PMID:
2475699
13.
14.

Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administration.

Lecocq B, Jaillon P, Lecocq V, Ferry A, Gardin ME, Jarreau C, Leroyer R, Pays M, Jarreau FX.

J Cardiovasc Pharmacol. 1988 Oct;12(4):445-50.

PMID:
2465445

Supplemental Content

Loading ...
Support Center